Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: ReportSwarajya StaffWednesday, January 5, 2022 05:29 PM IST
Bharat Biotech's Nasal Vaccine For Covid-19 Set To Advance Into Phase 2 Clinical TrialKaran KambleFriday, August 13, 2021 11:52 PM IST
Covid Vaccine Cocktail: Bharat Biotech To Test Covaxin-American Intranasal Candidate Combination In IndiaBhaswati Guha Majumder Saturday, July 31, 2021 03:17 PM IST
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In TrialsSwarajya StaffSaturday, July 31, 2021 10:41 AM IST